FDA Approved Uses of Cabozantinib

Oncology (Williston Park). 2019 Sep 20;33(9):685004.
No abstract available

MeSH terms

  • Anilides / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Neuroendocrine / drug therapy*
  • Carcinoma, Renal Cell / drug therapy*
  • Drug Approval / statistics & numerical data*
  • Humans
  • Kidney Neoplasms / drug therapy
  • Liver Neoplasms / drug therapy
  • Pyridines / therapeutic use*
  • Thyroid Neoplasms / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Anilides
  • Antineoplastic Agents
  • Pyridines
  • cabozantinib

Supplementary concepts

  • Thyroid cancer, medullary